Ocugen to Host Conference Call on Friday, May 6 at 8:30 a.m. ET to Provide Business Update and Discuss First Quarter 2022 Financial Results
May 02 2022 - 6:37AM
Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on
discovering, developing and commercializing novel gene therapies,
biologicals and vaccines, today announced that it will host a
conference call to provide a business update and discuss its first
quarter 2022 financial results at 8:30 a.m. ET on Friday, May 6,
2022.
Ocugen will issue a pre-market earnings announcement on the same
day. Investors are invited to participate on the call using the
following details:
- Dial-In Number: (844) 873-7330 (toll free) or (602) 563-8473
(Int’l)
- Conference ID: 6995784
- Webcast: Available in the “Investors” section of the Ocugen
website and archived for approximately 45 days following the
call
About Ocugen, Inc. Ocugen, Inc. is a
biotechnology company focused on discovering, developing, and
commercializing novel gene therapies, biologicals and vaccines that
improve health and offer hope for people and global communities. We
are making an impact through courageous innovation, taking science
in new directions in service of patients. Our breakthrough modifier
gene therapy platform has the potential to treat multiple diseases
with one drug and we are advancing research in other therapeutic
areas to offer new options for people with unmet medical needs.
Discover more at www.ocugen.com and follow us on Twitter and
LinkedIn.
Cautionary Note on Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of The Private Securities Litigation Reform Act of 1995,
which are subject to risks and uncertainties. Such forward-looking
statements within this press release include, without limitation,
the intended use of net proceeds from the registered direct
offering. We may, in some cases, use terms such as “predicts,”
“believes,” “potential,” “proposed,” “continue,” “estimates,”
“anticipates,” “expects,” “plans,” “intends,” “may,” “could,”
“might,” “will,” “should” or other words that convey uncertainty of
future events or outcomes to identify these forward-looking
statements. Such statements are subject to numerous important
factors, risks and uncertainties that may cause actual events or
results to differ materially from our current expectations, such as
market and other conditions. These and other risks and
uncertainties are more fully described in our periodic filings with
the Securities and Exchange Commission (the “SEC”), including the
risk factors described in the section entitled “Risk Factors” in
the quarterly and annual reports that we file with the SEC. Any
forward-looking statements that we make in this press release speak
only as of the date of this press release. Except as required by
law, we assume no obligation to update forward-looking statements
contained in this press release whether as a result of new
information, future events or otherwise, after the date of this
press release.
Ocugen Contact:Ken InchaustiHead, Investor
Relations & Communicationsken.inchausti@ocugen.com
Please submit investor-related inquiries to: IR@ocugen.com
Ocugen (NASDAQ:OCGN)
Historical Stock Chart
From Apr 2024 to May 2024
Ocugen (NASDAQ:OCGN)
Historical Stock Chart
From May 2023 to May 2024